Bionano Genomics Inc
(BNGO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,516 | -7,852 | -18,496 | -12,085 | -7,159 |
| Depreciation Amortization | 537 | 270 | 1,321 | 1,170 | 779 |
| Accounts receivable | -469 | 457 | -900 | -387 | 228 |
| Accounts payable and accrued liabilities | 2,257 | -511 | -954 | 61 | -1,058 |
| Other Working Capital | -246 | -641 | -2,369 | -2,597 | -1,651 |
| Other Operating Activity | 569 | 1,725 | 1,455 | -2,016 | -892 |
| Operating Cash Flow | $-12,868 | $-6,552 | $-19,944 | $-15,854 | $-9,754 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | N/A | -332 | -320 | -189 |
| Investing Cash Flow | $-30 | $N/A | $-332 | $-320 | $-189 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,106 | N/A | N/A | N/A | N/A |
| Debt Issued | 19,207 | 19,207 | 23,831 | 23,863 | 23,992 |
| Debt Repayment | -10,812 | -10,812 | -7,448 | -7,448 | -7,448 |
| Common Stock Issued | 2,475 | 2,464 | 19,394 | 19,394 | 1 |
| Other Financing Activity | -306 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $11,670 | $10,859 | $35,776 | $35,809 | $16,546 |
| Beginning Cash Position | 16,523 | 16,523 | 1,022 | 1,022 | 1,022 |
| End Cash Position | 15,295 | 20,830 | 16,523 | 20,657 | 7,624 |
| Net Cash Flow | $-1,228 | $4,307 | $15,501 | $19,635 | $6,602 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,868 | -6,552 | -19,944 | -15,854 | -9,754 |
| Capital Expenditure | -30 | N/A | -332 | -320 | -189 |
| Free Cash Flow | -12,898 | -6,552 | -20,276 | -16,174 | -9,943 |